Theospirex retard

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Theospirex retard

Quick Facts

Property Description
Active ingredient Choline Theophyllinate (Oxtriphylline)
Form Prolonged-release tablet (Retard)
Pharmacological class Xanthine derivative, Bronchodilator
Common use Systemic management of obstructive airway diseases
Origin Synthetic derivative

Definition and Pharmacological Class of Theospirex retard

Theospirex retard is an oral pharmaceutical preparation classified as a bronchodilator medicine, intended for the systemic management of chronic airway constriction. The medication's active ingredient is Choline Theophyllinate, also known by the International Nonproprietary Name (INN) Oxtriphylline. Chemically, this substance is a salt of theophylline and choline, placing the drug within the xanthine derivative pharmacological class. As a synthetic derivative, Choline Theophyllinate is highly soluble, and upon ingestion, it releases the pharmacologically active theophylline component. This class of medicine is intended to provide sustained therapeutic action in individuals requiring long-term control of respiratory symptoms.


The Prolonged-Release Tablet Form: Understanding the "Retard" Designation

The physical form of the medicine is a prolonged-release tablet, distinguished by the term "retard," which signifies a modified-release dosage form. This specific tablet structure is engineered using solid excipients to control the rate at which Choline Theophyllinate is released. The function of this sustained-release mechanism is to deliver the active substance consistently into the bloodstream over many hours, aiming to maintain a therapeutic effect throughout the day and night without the sharp concentration peaks associated with immediate-release forms. This prolonged-release feature is a key differentiator, making Theospirex retard suitable for managing symptoms requiring stable, continuous support.


General Purpose: Sustained Support for Airway Function

The general purpose of using Theospirex retard is to provide continuous, underlying support for pulmonary function in individuals with obstructive airway diseases. The released theophylline acts to relax the smooth muscle surrounding the bronchi, the main air passages in the lungs. This physiological action facilitates the widening of constricted airways, offering sustained relief from chronic symptoms such as wheezing and persistent difficulty in breathing. This medication is utilized under the guidance of a healthcare professional, as it is a prescription-only medicine.

Advertisements

What side effects are possible with Theospirex retard?

Possible Side Effects and Safety Information

The safety profile of Theospirex retard, which releases the active component theophylline, is structured by the systemic classification of adverse reactions and their concentration-dependency in the blood. Official regulatory documents categorize possible effects across major physiological systems.

Documented Adverse Reactions

Adverse reactions are classified into System-Organ Classes (SOCs) in official labeling. The most frequently documented effects often involve the following systems:

  • Nervous System Disorders: May include headache, tremors (especially in the hands), dizziness, restlessness, and insomnia (sleeplessness).
  • Gastrointestinal Disorders: Frequently reported effects include nausea, vomiting, diarrhea, and epigastric pain (stomach upset).
  • Cardiac Disorders: May include palpitations and an increased heart rate (tachycardia).

Serious Adverse Reactions and Risk Factors

The risk of developing serious adverse reactions is formally documented to increase significantly when the serum concentration of theophylline exceeds the target therapeutic range. Serious complications listed in regulatory documents include seizures and life-threatening cardiac arrhythmias, such as ventricular arrhythmias. Theophylline is officially classified as having a Narrow Therapeutic Index (NTI).

Population-Specific Safety Considerations

Specific safety considerations are noted for certain populations due to the potential for altered drug clearance, which increases the risk of toxicity. Regulatory information highlights the need for particular caution in geriatric patients (older adults) and individuals with conditions that affect drug metabolism, such as hepatic impairment (liver disease) or congestive heart failure. Official labeling also notes that some effects, such as headache and tremors, may be transient and may diminish after the first week of treatment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Theospirex retard (Choline Theophyllinate, which releases theophylline) overdose emphasizes rapid recognition of severe symptoms and immediate emergency action.

Documented Overdose Manifestations

Overdose presentations are generally dose-related and affect multiple body systems. The severity and frequency of these symptoms increase with rising serum concentrations of theophylline. Symptoms include:

  • Gastrointestinal: Nausea, vomiting (which may be severe or repetitive), and abdominal pain.
  • Central Nervous System (CNS): Restlessness, tremors, headache, irritability, and insomnia.
  • Cardiovascular: Tachycardia (rapid heartbeat), palpitations, and hypotension.

Severe and Life-Threatening Outcomes

Serious toxicity is classified by the potential for life-threatening complications, which are documented to include:

  • Neurological: Seizures (which may progress to status epilepticus) and coma.
  • Cardiovascular: Severe cardiac arrhythmias (including ventricular fibrillation) and cardiac arrest.
  • Metabolic: Significant hypokalemia (low potassium levels) and hyperglycemia.

Emergency Action and Urgent Help-Seeking

Immediate medical attention is required for any suspected overdose or upon the onset of severe manifestations, such as repeated vomiting, seizures, or rapid, irregular heartbeats.

Regulatory documentation mandates the immediate withholding of the drug when signs of toxicity are present. Management involves rigorous supportive care and monitoring, often including measures to enhance drug elimination, such as the administration of activated charcoal or, for severe cases, hemodialysis. There is no specific antidote officially listed for theophylline overdose.

Population-Specific Notes

The risk of severe toxicity is heightened in the elderly and in patients with reduced drug clearance due to conditions like liver disease or congestive heart failure.

Advertisements

Therapeutic Uses of Theospirex retard

What Theospirex retard Treats: Main Uses and Benefits

Theospirex retard is an oral medication containing Choline Theophyllinate (which releases theophylline) and is generally used in the long-term management of conditions characterized by periods of heightened symptoms, such as Chronic Obstructive Pulmonary Disease (COPD) and Bronchial Asthma. This class of medication is commonly used to help with symptoms caused by chronic bronchitis and emphysema.

Symptom Support and Sustained Stability

The medication is applied across domains where additional symptomatic support is needed, addressing symptom clusters that interfere with daily functioning, including chronic difficulty in breathing, shortness of breath (dyspnea), and recurrent wheezing. Its sustained action may assist with providing continuous support, which is relevant for managing symptoms that become more disruptive during flare-ups, such as nocturnal symptoms. This therapeutic approach supports general well-being during symptomatic phases.

“The sustained action supports general well-being during symptomatic phases.”

Quick Fact: Supportive Management for Wheezing

Feature Therapeutic Context
Primary Domain Applied across domains where additional symptomatic support is needed for conditions involving chronic airflow limitation.
Symptoms Targeted Symptoms related to physical discomfort like persistent difficulty in breathing, wheezing, and shortness of breath.
Context of Use Maintenance therapy for long-term symptom control.
Key Benefit Supports the patient during difficult episodes by easing distress.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Theospirex retard?

The official eligibility profile for Theospirex retard is strictly defined by regulatory authorities based on age, acute conditions, and specific health statuses that affect how the body processes the medicine.

Population Status Eligibility Rule
Contraindicated Children under 6 years of age (for this prolonged-release form); Patients concurrently using other xanthine derivatives; Patients with known hypersensitivity to theophylline; Use during an acute asthma attack or status asthmaticus is prohibited.
Restricted/Caution Elderly patients (over 60 years); Patients with hepatic impairment (e.g., cirrhosis); Use during acute illness with fever (requires close monitoring); Tobacco smokers (requires dose adjustment due to increased clearance).

The medicine is permitted for use in adults, adolescents, and children aged 6 years and older for chronic management, provided no contraindications are present. Use during pregnancy is restricted, as the substance crosses the placenta, and its clearance is reduced during the third trimester. During lactation, theophylline passes into breast milk, necessitating careful medical evaluation of the benefits and risks to the nursing infant.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Theospirex retard contains theophylline, a substance with a narrow therapeutic range, meaning its blood concentration must be carefully controlled. Many medicinal products and lifestyle factors can alter theophylline's clearance in the body, leading to either dangerously high or subtherapeutic levels.

Pharmacokinetic Interactions (Altered Theophylline Concentration)

Classification Examples of Interacting Agents Resulting Effect on Theophylline Concentration
Clearance Inhibitors Specific antibiotics (e.g., fluoroquinolones, macrolides), cimetidine, verapamil, allopurinol (high dose), disulfiram, fluvoxamine, estrogens, alcohol. Increased (risk of toxicity).
Clearance Inducers Phenytoin, phenobarbital, carbamazepine, rifampin, aminoglutethimide, tobacco smoking. Decreased (risk of reduced efficacy).

Pharmacodynamic Interactions (Altered Effects)

  • Enhanced Effects: Concomitant use with other xanthine derivatives (like caffeine) or sympathomimetics (e.g., ephedrine) may enhance central nervous system stimulation and increase the risk of adverse effects. Theophylline may also enhance the effect of diuretics and cardiac glycosides.
  • Reduced Effects: Theophylline may diminish the effect of beta-adrenergic blockers and the sedative effects of benzodiazepines.
  • Other Risks: Concurrent use with halothane may increase the risk of severe cardiac arrhythmias. Theophylline may also increase the renal clearance of lithium salts, thereby reducing lithium blood levels.

Due to the complexity and severity of these interactions, theophylline plasma levels must be monitored frequently when starting, stopping, or changing the dose of any potentially interacting medicinal product.

Advertisements

Mechanism of Action

Theophylline, the active substance in Theospirex retard, works through a dual pharmacodynamic mechanism involving enzymatic inhibition and receptor antagonism. The molecule acts as a non-selective inhibitor of Phosphodiesterase (PDE) enzymes, particularly PDE3 and PDE4. This inhibition prevents the breakdown of the second messenger cyclic adenosine monophosphate (cAMP), leading to its accumulation in bronchial smooth muscle cells. The resulting intracellular cascade decreases the tension of the smooth muscle, leading to an increase in airway caliber.

Concurrently, Theophylline functions as a non-selective antagonist against cell-surface Adenosine Receptors (A1 and A2B), influencing the set point of airway reactivity and modulating the force generation potential of respiratory muscles. A distinct action involves the restoration of function to the nuclear enzyme Histone Deacetylase-2 (HDAC2). This restoration limits the transcriptional activity of the pro-inflammatory transcription factor NF-kappa B, thereby contributing to the genomic modulation of inflammatory pathways within the cellular architecture of the airway walls.

Advertisements

Dosage and Administration Information

How to use Theospirex retard — Official Administration Guidelines

Administration of Theospirex retard (a prolonged-release tablet) is guided by official instructions focused on achieving a stable concentration of the active ingredient in the body, primarily through clinical monitoring.


Administration Scope

Instruction Domain Official Guideline
Route of administration The medication is approved for Oral administration.
Dosing schedule Dosage is highly individualized and determined by Therapeutic Drug Monitoring (TDM) to achieve target serum concentrations. Initial adult doses are generally 300 mg to 400 mg per day.
Timing in relation to meals Can be taken with or without food; however, ingestion with food may prolong the absorption time of the active ingredient.
Preparation requirements None. The prolonged-release tablet must be swallowed whole and should not be crushed, broken, or chewed to preserve the controlled-release mechanism.
Age-group administration rules Older adults may require a lower daily maximum, often not more than 400 mg per day. Pediatric dosing (for certain age and weight groups) is determined based on body weight.
Missed-dose rules If a dose is forgotten but remembered within 4 hours of the scheduled time, the dose can be taken immediately. If more than 4 hours have passed, the next dose should be taken at the normal scheduled time.
Special procedural conditions Requires periodic monitoring of serum concentrations during long-term use. Dose adjustment is required whenever there is a new illness or a significant change in the patient's treatment regimen.

Instruction classifications (high-level)

Classification Official Pattern
Administration method type Oral
Frequency pattern Daily (typically once or twice daily); must be taken at the same time each day.
Basis of use Standard pharmaceutical guidelines
Use-context constraints Therapeutic Drug Monitoring (TDM) mandatory for all dosing adjustments.

Resulting Procedural Structure

Official step sequence:

  • The extended-release tablet is administered orally and must be swallowed whole.
  • The dose is determined by the required serum concentration, which is confirmed through TDM.
  • During maintenance, periodic serum monitoring is required to ensure the dose remains stable and appropriate.

Connection to the overall use protocol: The official instructions establish an individualized protocol where the route of administration is fixed as oral, but the dose is determined by clinical monitoring. This procedural focus requires swallowing the intact prolonged-release tablet and adhering to guidelines for dosage adjustments. Consequently, the established use of the drug is procedural and defined by required, recurring concentration testing during maintenance.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Theospirex retard

Evidence for Use in Chronic Obstructive Pulmonary Disease (COPD)

This section will summarize the types of clinical trials, including randomized controlled trials and meta-analyses, that have studied the use of this medication in adults with stable, chronic COPD and the physiological and clinical outcomes that were measured.

Studies explored the use in adults with Chronic Obstructive Pulmonary Disease (COPD), including patients with moderate to very severe symptoms. Research examined objective airway function, such as measured lung capacity ( FEV1), and studies explored outcomes related to systemic or functional imbalance. The research also closely monitored clinical events, particularly the frequency of COPD exacerbations (or flare-ups) and hospital admissions over defined time intervals.

Study Focus: Lung Function and Symptom Measures

Research describes measurements of changes in physiological outcomes. Studies conducted during periods of increased symptom activity were applied in trials assessing episodic symptom patterns, where patient-reported outcomes describing perceived discomfort were measured using standardized quality of life scales. Findings describe patterns observed in these studies, where symptom patterns were monitored. However, it is important to note that the bulk of this evidence contributes to understanding symptom patterns and is often derived from older or smaller RCTs.

Study Focus: Exacerbation Rates and Clinical Events

Studies monitored the impact on clinical events, such as the total number of COPD exacerbations over a long-term follow-up duration (up to a year). Large trials have been conducted in high-risk patients who were already receiving standard inhaled maintenance therapy. Research highlights changes measured during the study period, but findings were mixed regarding whether data showed patterns related to a measurable difference in the total annualized rate of COPD exacerbations compared to placebo. Data show patterns related to high variability in how individuals handle the drug, which can influence the consistency of the clinical observations.

Evidence for Use in Bronchial Asthma

This section will outline the structure of the research base, which includes older crossover trials and systematic reviews, that examined the medication's effects on respiratory function and symptoms, including those that occur overnight.

Studies explored the use of this medication in managing conditions characterized by fluctuating or episodic manifestations, such as chronic asthma. Research was evaluated in studies examining objective airway function, like Peak Expiratory Flow Rate, and focused particularly on outcomes describing episodic or acute changes in symptoms, such as nocturnal wheezing. Short-term crossover trials, conducted over defined time intervals, reported patterns where findings described changes in overnight airway constriction and improvements in patient-reported outcomes describing perceived discomfort and quality of sleep.

Key Studies & References

  1. Theophylline - StatPearls - NCBI Bookshelf - NIH (Overview of Indications and Mechanism)
  2. Theophylline: MedlinePlus Drug Information (General Overview and Indications)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Theospirex retard (FAQ)


Q: Is Theospirex retard the same kind of drug as an inhaler?

Theospirex retard is an oral medication that works systemically, meaning the active substance travels through the bloodstream to affect the airways. While it belongs to the same therapeutic class as many inhaled medicines (bronchodilators), its route of administration and primary pharmacological action within the body are different from those designed to act locally in the lungs.


Q: Can people with liver problems or kidney issues take this medication?

Official product information indicates that the medication is used with caution in patients with hepatic impairment, or liver disease, due to the potential for increased theophylline concentration. For adults with kidney issues (renal insufficiency), dose adjustment is typically not specified, but close medical oversight is associated with these conditions.


Q: Can Theospirex retard be taken with other heart medications?

According to regulatory documents, theophylline interacts with many cardiovascular medicines, including certain beta-adrenergic blockers and the calcium channel blocker verapamil. Due to the complexity of these drug interactions, careful medical monitoring and dosage adjustment are typically necessary when combining these medicines.


Q: Is the 'retard' formulation designed to reduce specific side effects?

The prolonged-release ('retard') formulation is engineered to deliver the medication consistently, which is designed to maintain a stable concentration in the body and avoid the high concentration peaks associated with immediate-release versions. Official safety information shows that the risk of serious adverse reactions, such as seizures or cardiac arrhythmias, increases significantly when the drug's concentration exceeds the therapeutic range.


Q: Are there any common reasons why a prescription for Theospirex retard might be stopped?

Official documentation indicates that a prescription may be discontinued if serious complications, such as signs consistent with theophylline toxicity (including severe nausea, vomiting, or seizures), are present. Furthermore, the medicine may be stopped if life-threatening adverse reactions, like severe cardiac arrhythmias, occur. Doses are often withheld in clinical settings when these serious complications occur.


Q: If I switch from a different Theophylline drug to Theospirex retard, what should I expect?

Regulatory guidelines state that any change in a patient's existing treatment regimen, including switching formulations, is subject to professional oversight. A healthcare provider must monitor the serum concentration of theophylline and perform dose adjustment to ensure safe and effective therapeutic levels are maintained.


Q: Can people with high blood pressure safely use Theospirex retard?

Official warnings state that the medicine is used with caution in the presence of severe hypertension, or high blood pressure, as well as in patients with certain other cardiovascular diseases. Caution is necessary because theophylline is known to influence heart function.


Q: What happens if I accidentally take more than the prescribed amount?

An overdose can lead to severe, life-threatening symptoms, including seizures and serious disturbances in heart rhythm. Immediate medical attention is necessary if an overdose is suspected. Official information states that patients should not attempt to induce vomiting unless specifically directed by a healthcare professional.


Q: Does Theospirex retard affect blood sugar levels?

According to official regulatory documents, one of the reported adverse reactions associated with theophylline is hyperglycemia, which is the medical term for an increase in blood sugar levels.


Q: What should I do if the side effects seem severe?

The official documentation states that if signs of severe adverse reactions or toxicity occur, such as convulsions (seizures) or life-threatening cardiac arrhythmias, discontinuation of the medication and urgent medical evaluation are necessary.


Q: Is Theospirex retard listed as a medicine that affects driving ability?

Official safety information indicates that theophylline can cause effects such as dizziness, tremors, and nervous system stimulation. Because these adverse reactions may affect a person’s ability to operate machinery or vehicles, caution is noted in relation to using this medication.


Q: Does Theospirex retard affect the results of any common medical tests?

Regulatory documents state that theophylline may affect the results of certain common medical tests. Specifically, it has been shown to potentially increase urine catecholamines and plasma free fatty acids, as well as influencing the ratio of lithium to creatinine clearance.

Advertisements

How should Theospirex retard be stored and disposed of?

How to Store and Dispose of Theospirex retard

The storage of this medicine must comply with regulatory labeling to maintain its stability and effectiveness.

Storage Conditions

Requirement Official Labeled Condition
Temperature Store below 25 C
Protection Keep in the original container and protect from moisture
Child Safety Store out of the sight and reach of children

Disposal Instructions

Any unused or expired Theospirex retard tablets must be discarded in strict accordance with local requirements. The medicine should not be disposed of in household waste or wastewater unless explicitly permitted by local pharmaceutical waste guidelines.

These official rules ensure the integrity of the prolonged-release formulation and enforce safe handling and disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Theospirex retard found in:

A-Z Index: